• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国心力衰竭住院患者的时间趋势。

Temporal Trends of Hospitalized Patients with Heart Failure in Korea.

作者信息

Youn Jong-Chan, Han Seongwoo, Ryu Kyu-Hyung

机构信息

Division of Cardiology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.

出版信息

Korean Circ J. 2017 Jan;47(1):16-24. doi: 10.4070/kcj.2016.0429. Epub 2016 Dec 29.

DOI:10.4070/kcj.2016.0429
PMID:28154584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5287180/
Abstract

Heart failure (HF) is an important cardiovascular disease because of its increasing prevalence, significant morbidity, high mortality and rapidly expanding health care costs. The number of HF patients is increasing worldwide and Korea is no exception. Temporal trends of four representative Korean hospitalized HF registries-the Hallym HF study, the Korean Multicenter HF study, the Korean Heart Failure (KorHF) registry and the Korean Acute Heart Failure (KorAHF) registry showed mild survival improvement reflecting overall HF patient care development in Korea despite the increased severity of enrolled patients with higher incidence of multiple comorbidities. Moreover, device therapies such as implantable cardioverter defibrillator and cardiac resynchronization therapy and definitive treatment such as heart transplantation have been increasing in Korea as well. To prevent HF burden increase, it is essential to set up long term effective prevention strategies for better control of ischemic heart disease, hypertension and diabetes, which might be risk factors for HF development. Moreover, proper HF guidelines, performance measures, and performance improvement programs might be necessary to limit HF burden as well.

摘要

心力衰竭(HF)是一种重要的心血管疾病,因其患病率不断上升、发病率高、死亡率高且医疗费用迅速增加。全球范围内HF患者数量在不断增加,韩国也不例外。韩国四个具有代表性的住院HF登记处——翰林HF研究、韩国多中心HF研究、韩国心力衰竭(KorHF)登记处和韩国急性心力衰竭(KorAHF)登记处的时间趋势显示,尽管入组患者病情加重,多种合并症发生率更高,但生存率仍有轻度改善,这反映了韩国整体HF患者护理的发展。此外,在韩国,诸如植入式心脏复律除颤器和心脏再同步治疗等器械治疗以及诸如心脏移植等确定性治疗也在增加。为防止HF负担增加,必须制定长期有效的预防策略,以更好地控制缺血性心脏病、高血压和糖尿病,这些可能是HF发展的危险因素。此外,可能还需要适当的HF指南、绩效指标和绩效改进计划来限制HF负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/6bd89b5daceb/kcj-47-16-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/fd516fac0f58/kcj-47-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/c73668dfb284/kcj-47-16-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/514fb4e0da70/kcj-47-16-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/ded9dadbc588/kcj-47-16-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/fa3c3c10d99b/kcj-47-16-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/c780d3fa699c/kcj-47-16-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/cfbe4c0363de/kcj-47-16-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/6bd89b5daceb/kcj-47-16-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/fd516fac0f58/kcj-47-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/c73668dfb284/kcj-47-16-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/514fb4e0da70/kcj-47-16-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/ded9dadbc588/kcj-47-16-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/fa3c3c10d99b/kcj-47-16-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/c780d3fa699c/kcj-47-16-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/cfbe4c0363de/kcj-47-16-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a668/5287180/6bd89b5daceb/kcj-47-16-g008.jpg

相似文献

1
Temporal Trends of Hospitalized Patients with Heart Failure in Korea.韩国心力衰竭住院患者的时间趋势。
Korean Circ J. 2017 Jan;47(1):16-24. doi: 10.4070/kcj.2016.0429. Epub 2016 Dec 29.
2
Heart Failure Statistics in Korea, 2020: A Report from the Korean Society of Heart Failure.《2020年韩国心力衰竭统计数据:来自韩国心力衰竭学会的报告》
Int J Heart Fail. 2021 Sep 8;3(4):224-236. doi: 10.36628/ijhf.2021.0023. eCollection 2021 Oct.
3
The Third Nationwide Korean Heart Failure III Registry (KorHF III): The Study Design Paper.第三届全国韩国心力衰竭III注册研究(KorHF III):研究设计论文
Int J Heart Fail. 2024 Apr 1;6(2):70-75. doi: 10.36628/ijhf.2024.0001. eCollection 2024 Apr.
4
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.
5
The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry.超声心动图在急性失代偿性心力衰竭短期随访中的有限预后作用:韩国心力衰竭(KorHF)注册研究分析
PLoS One. 2017 Dec 19;12(12):e0188938. doi: 10.1371/journal.pone.0188938. eCollection 2017.
6
Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).在轻度心力衰竭患者中(来自MADIT-CRT研究),植入式心律转复除颤器或心脏再同步化治疗除颤器之前心力衰竭住院对后续结局的时间影响
Am J Cardiol. 2015 May 15;115(10):1423-7. doi: 10.1016/j.amjcard.2015.02.029. Epub 2015 Feb 18.
7
Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.轻度心力衰竭患者血压与长期预后的负相关关系及心脏再同步治疗的益处:一项心脏再同步治疗长期随访亚研究的多中心自动除颤器植入试验
Circ Heart Fail. 2015 Sep;8(5):921-6. doi: 10.1161/CIRCHEARTFAILURE.115.002208. Epub 2015 Jul 15.
8
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.植入式心脏复律除颤器用于一级预防的心力衰竭患者合并症与预后的关系
J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.
9
Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry.心力衰竭住院患者中与糖尿病相关的时间趋势和因素:来自“遵循指南-心力衰竭”注册研究的结果
Am Heart J. 2016 Dec;182:9-20. doi: 10.1016/j.ahj.2016.07.025. Epub 2016 Aug 27.
10
Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.无左束支传导阻滞的轻度心力衰竭患者中QRS时限与心脏再同步治疗临床获益的关系:心脏再同步治疗多中心自动除颤器植入试验子研究
Circ Heart Fail. 2016 Feb;9(2):e002667. doi: 10.1161/CIRCHEARTFAILURE.115.002667.

引用本文的文献

1
Rationale, Design, and Interim Observations of the Steady Movement With Innovating Leadership for Heart Failure (SMILE HF) Registry: A Multicenter Prospective Cohort Registry for Patients With Acute Heart Failure.心力衰竭创新领导力稳步运动(SMILE HF)注册研究的原理、设计与中期观察:一项针对急性心力衰竭患者的多中心前瞻性队列注册研究
Int J Heart Fail. 2024 Jul 11;6(3):129-136. doi: 10.36628/ijhf.2024.0014. eCollection 2024 Jul.
2
Temporal Trends in Clinical Characteristics and Outcomes for Peripartum Cardiomyopathy: The Nationwide Multicenter Registry Over 20 Years.围生期心肌病的临床特征和结局的时间趋势:20 多年来的全国多中心登记研究。
J Am Heart Assoc. 2024 Jul 2;13(13):e034055. doi: 10.1161/JAHA.123.034055. Epub 2024 Jun 21.
3

本文引用的文献

1
Epidemiology of Heart Failure in Korea: Present and Future.韩国心力衰竭的流行病学:现状与未来。
Korean Circ J. 2016 Sep;46(5):658-664. doi: 10.4070/kcj.2016.46.5.658. Epub 2016 Sep 28.
2
Heart Failure Epidemic: an Expected Phenomenon.心力衰竭流行:一种预期现象。
Korean Circ J. 2016 Sep;46(5):610-612. doi: 10.4070/kcj.2016.46.5.610. Epub 2016 Sep 28.
3
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea.韩国射血分数全谱心力衰竭患者达格列净的资格和成本-效用分析。
Am J Cardiovasc Drugs. 2024 Mar;24(2):313-324. doi: 10.1007/s40256-024-00632-w. Epub 2024 Feb 27.
4
Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea.韩国恩格列净治疗心力衰竭的真实世界准入和成本效益分析。
J Korean Med Sci. 2024 Jan 8;39(1):e8. doi: 10.3346/jkms.2024.39.e8.
5
The characteristic large-scale annual analysis by gender and age in heart failure patients: cohort for 10 years in Korea.心力衰竭患者的特征性大规模年度性别和年龄分析:韩国 10 年队列研究。
ESC Heart Fail. 2023 Dec;10(6):3515-3524. doi: 10.1002/ehf2.14528. Epub 2023 Sep 21.
6
Heart Failure Awareness Among the General Saudi Population: A Cross-Sectional Study.沙特普通人群对心力衰竭的认知:一项横断面研究。
Cureus. 2023 Jul 18;15(7):e42077. doi: 10.7759/cureus.42077. eCollection 2023 Jul.
7
A machine-learning-based prediction of non-home discharge among acute heart failure patients.基于机器学习的急性心力衰竭患者非居家出院预测。
Clin Res Cardiol. 2024 Apr;113(4):522-532. doi: 10.1007/s00392-023-02209-0. Epub 2023 May 3.
8
Eligibility and Usage of Sacubitril/Valsartan in Korea.沙库巴曲缬沙坦在韩国的适用情况及使用方法。
Int J Heart Fail. 2019 Oct 29;1(1):69-71. doi: 10.36628/ijhf.2019.0008. eCollection 2019 Oct.
9
The Long Journey to Obtaining the Epidemiological Data of Heart Failure in Korea.获取韩国心力衰竭流行病学数据的漫长历程。
Int J Heart Fail. 2021 Oct 6;3(4):221-223. doi: 10.36628/ijhf.2021.0036. eCollection 2021 Oct.
10
Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure.探讨沙库巴曲缬沙坦在心力衰竭中的现代治疗选择和结局。
Int J Mol Sci. 2022 Sep 26;23(19):11336. doi: 10.3390/ijms231911336.
2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
4
Epidemiology and aetiology of heart failure.心力衰竭的流行病学和病因学。
Nat Rev Cardiol. 2016 Jun;13(6):368-78. doi: 10.1038/nrcardio.2016.25. Epub 2016 Mar 3.
5
Temporal Trends in Hospitalization for Acute Decompensated Heart Failure in the United States, 1998-2011.1998 - 2011年美国急性失代偿性心力衰竭住院治疗的时间趋势
Am J Epidemiol. 2016 Mar 1;183(5):462-70. doi: 10.1093/aje/kwv455. Epub 2016 Feb 19.
6
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
7
Epidemiology of Heart Failure in Asia.亚洲心力衰竭流行病学
Heart Fail Clin. 2015 Oct;11(4):573-9. doi: 10.1016/j.hfc.2015.07.009.
8
Heart Transplant in Asia.亚洲的心脏移植
Heart Fail Clin. 2015 Oct;11(4):563-72. doi: 10.1016/j.hfc.2015.07.008.
9
Prognostic Factors in Hospitalization for Heart Failure in Asia.亚洲心力衰竭住院治疗的预后因素
Heart Fail Clin. 2015 Oct;11(4):543-50. doi: 10.1016/j.hfc.2015.07.006. Epub 2015 Aug 20.
10
Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF.NT-proBNP在射血分数保留型与射血分数降低型心力衰竭中的预后价值。
Heart. 2015 Dec;101(23):1881-8. doi: 10.1136/heartjnl-2015-307782. Epub 2015 Aug 28.